Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
362-06-016 ISMRM Abstract

Quantitative Assessment of CSF-Vascular Coupling in Alzheimer’s Disease Using Phase-Contrast and 4D-Flow MRI

Primary: Neuro - Alzheimer's Disease
Secondary: Contrast Mechanisms - Velocity/Flow
362-06-016 · Neuroimaging Biomarkers of Aging, Vascular Health, and Dementia · Monday, 11 May, 5:05 PM–6:00 PM · Digital Posters Row C
Keywords: Alzheimer's Disease 4D flow MRI Cerebrospinal fluid Phase-contrast MRI
Accepted
Mengying Lu 1,2,3, Jialu Zhang4, Yushan Zheng1,2,3, Dingtai Wei1,2,3
1Department of Clinical Medicine, Fujian Medical University, Fuzhou, China
2Department of Radiology, Ningde Municipal Hospital of Ningde Normal University, Ningde, China
3Functional and Molecular Imaging Laboratory for Cerebral Vascular Diseases, Ningde Municipal Hospital of Ningde Normal University, Ningde, China
4MR Research, Beijing, China
Presenting Author: Mengying Lu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013 Nov 20;80(4):844-66. doi: 10.1016/j.neuron.2013.10.008. PMID: 24267647; PMCID: PMC3842016. [doi] [pmid]
2. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. PMID: 29653606; PMCID: PMC5958625. [doi] [pmid]
3. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0. Erratum in: Lancet Neurol. 2014 Aug;13(8):757. PMID: 24849862. [doi] [pmid]
4. Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease. Alzheimers Res Ther. 2019 Apr 22;11(1):34. doi: 10.1186/s13195-019-0485-0. PMID: 31010420; PMCID: PMC6477717. [doi] [pmid]
5. Bacyinski A, Xu M, Wang W, Hu J. The Paravascular Pathway for Brain Waste Clearance: Current Understanding, Significance and Controversy. Front Neuroanat. 2017 Nov 7;11:101. doi: 10.3389/fnana.2017.00101. PMID: 29163074; PMCID: PMC5681909. [doi] [pmid]
6. Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017 Sep 27;96(1):17-42. doi: 10.1016/j.neuron.2017.07.030. PMID: 28957666; PMCID: PMC5657612. [doi] [pmid]
7. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012 Aug 15;4(147):147ra111. doi: 10.1126/scitranslmed.3003748. PMID: 22896675; PMCID: PMC3551275. [doi] [pmid]
8. Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020 Oct 2;370(6512):50-56. doi: 10.1126/science.abb8739. PMID: 33004510; PMCID: PMC8186542. [doi] [pmid]
9. Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun. 2016 Jun 21;7:11934. doi: 10.1038/ncomms11934. PMID: 27327500; PMCID: PMC4919512. [doi] [pmid]
10. Markl M, Frydrychowicz A, Kozerke S, Hope M, Wieben O. 4D flow MRI. J Magn Reson Imaging. 2012 Nov;36(5):1015-36. doi: 10.1002/jmri.23632. PMID: 23090914. [doi] [pmid]
11. Rivera-Rivera LA, Schubert T, Turski P, Johnson KM, Berman SE, Rowley HA, Carlsson CM, Johnson SC, Wieben O. Changes in intracranial venous blood flow and pulsatility in Alzheimer's disease: A 4D flow MRI study. J Cereb Blood Flow Metab. 2017 Jun;37(6):2149-2158. doi: 10.1177/0271678X16661340. Epub 2016 Jan 1. PMID: 27492950; PMCID: PMC5464708. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/362-06-016